Abstract： Objective To investigate the miRNA expression profiles in rectal cancer tissues and their associations with clinical pathological stage, depth of tumor invasion, and lymph node metastasis, and to evaluate the potential of miRNA as diagnostic and prognostic markers of rectal cancer. Methods Human miRNA microarray was used to profile miRNA expression in rectal cancer tissues and matched adjacent normal tissues (n=71). The up-regulated miR-93-5p and down-regulated miR-27a-3p were screened out, and the top differentially expressed miRNA were validated by quantitative real-time polymerase chain reaction (qRT-PCR). The relationship between the expression of miRNA and clinical parameters was analyzed by ANOVA and Spearman correlation. Results The expression of miR-27a-3p was down-regulated in miRNA microarray, but was up-regulated in qRT-PCR analysis;the data were relatively discrete. The expression of miR-93-5p was up-regulated in both miRNA microarray and qRT-PCR analysis;the expression level of miR-93-5p in rectal cancer tissues was 3.165 times that in adjacent normal tissues (P=0.0058);the expression level was correlated with tumor volume (P=0.004), and was positively correlated with the level of carcinoembryonic antigen (CEA) before treatment (P=0.001) and the number of lymph nodes metastases (rs=0.534, P=0.005). Conclusions There is a differential miRNA expression pattern between rectal cancer tissues and matched adjacent normal tissues. The miR-93-5p is highly up-regulated in rectal cancer tissues and may serve as a diagnostic and prognostic marker of rectal cancer.
Hu Yiran,Hu Peng,Wu Quan et al. Expression of miR-93-5p and miR-27a-3p in rectal cancer tissues and its clinical significance[J]. Chinese Journal of Radiation Oncology, 2017, 26(10): 1156-1161.
[1] Kondo K,Shimbo T,Tanaka K,et al. Clinical implications of preoperative chemoradiotherapy prior to laparoscopic surgery for locally advanced low rectal cancer[J].Mol Clin Oncol,2017,6(1):23-28.DOI:10.3892/mco.2016.1098. [2] Ajit SK.Circulating microRNAs as biomarkers,therapeutic targets,and signaling molecules[J].Sensors,2012,12(3):3359-3369.DOI:10.3390/s120303359. [3] 朱林林,陈薇,王瑾等.正常结直肠组织、腺瘤、结直肠腺癌中miRNAs的表达差异[J].四川大学学报(医学版),2015,46(6):851-855. Zhu LL,Chen W,Wang J,et al. Expression difference of microRNAs in colorectal adenoma and colorectal cancer[J].J Sichuan Univ (Med Sci ed),2015,46(6):851-855. [4] Qu YL,Wang HF,Sun ZQ,et al. Up-regulated miR-155-5p promotes cell proliferation,invasion and metastasis in colorectal carcinoma[J].Int J Clin Exp Pathol,2015,8(6):6988-6994. [5] Yang LQ,Luo PC,Fei XJ,et al. A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1[J].Cancer Med,2016,5(8):2022-2031.DOI:10.1002/cam4.760. [6] Tsukamoto M,Iinuma H,Yagi T,et al. Circulating exosomal microRNA-21 as a biomarker in each tumor stage of colorectal cancer[J].Oncology,2017,92(6):360-370.DOI:10.1159/000463387. [7] Zhu MX,Huang ZB,Zhu DX,et al. A panel of microRNA signature in serum for colorectal cancer diagnosis[J].Oncotarget,2017,8(10):17081-17091.DOI:10.18632/oncotarget.15059. [8] Zhou L,Liang X,Zhang LL,et al. MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2[J].Oncotarget,2016,7(32):51943-51954.DOI:10.18632/oncotarget.10460. [9] Nakata W,Uemura M,Sato M,et al. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma[J].Oncotarget,2015,6(25):21645-21654.DOI:10.18632/oncotarget.4064. [10] Tang W,Zhu JJ,Su SC,et al. MiR-27 as a prognostic marker for breast cancer progression and patient survival[J].PLoS One,2012,7(12):e51702.DOI:10.1371/journal.pone.0051702. [11] Eriksen AHM,Andersen RF,Pallisgaard N,et al. MicroRNA expression profiling to identify and validate reference genes for the relative quantification of microRNA in rectal cancer[J].PLoS One,2016,11(3):e0150593.DOI:10.1371/journal.pone.0150593. [12] Pellatt DF,Stevens JR,Wolff RK,et al. Expression profiles of miRNA subsets distinguish human colorectal carcinoma and normal colonic mucosa[J].Clin Transl Gastroenterol,2016,7(3):e152.DOI:10.1038/ctg.2016.11. [13] Tan YG,Zhang YF,Guo CJ,et al. Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer[J].Asian Pac J Trop Med,2013,6(12):972-976.DOI:10.1016/ S1995-7645(13)60174-1. [14] Xiao ZG,Deng ZS,Zhang YD,et al. Clinical significance of microRNA-93 downregulation in human colon cancer[J].Eur J Gastroenterol Hepatol,2013,25(3):296-301.DOI:10.1097/MEG. 0b013e32835c077a. [15] Yang IP,Tsai HL,Miao ZF,et al. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients[J].J Transl Med,2016,14(1):108.DOI:10.1186/s12967-016-0856-2. [16] Compton C,Fenoglio-Preiser CM,Pettigrew N,et al. American joint committee on cancer prognostic factors consensus conference:colorectal working group[J].Cancer,2000,88(7):1739-1757.DOI:10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T. [17] Ryu YJ,Kim CH,Kim HJ,et al. Clinical significance of serial serum carcinoembryonic antigen values for treating rectal cancer with preoperative chemoradiotherapy[J].J Korean Soc Coloproctol,2012,28(4):205-212.DOI:10.3393/jksc.2012.28.4.205. [18] Tarantino I,Warschkow R,Worni M,et al. Elevated preoperative CEA is associated with worse survival in stage Ⅰ—Ⅲ rectal cancer patients[J].Br J Cancer,2012,107(2):266-274.DOI:10.1038/bjc.2012.267.
2017, Vol. 26 
